Arogyavardhini Vati
Polyherbal liquid
Arogyavardhini Vati is a revered Ayurvedic polyherbal-mineral formulation, widely used for its supposed broad spectrum of health benefits. Its name translates to "health enhancer," reflecting its claimed effects on balancing Vata, Pitta, and Kapha doshas. It's prevalent for its supposed support in liver health, digestion, and detoxification, often used for chronic conditions and skin ailments.
PLANT FAMILY
Several Families
AYURVEDIC ACTION
Pitta ↓, Kapha ↓, Vata ↑
ACTIVE COMPOUNDS
Not a single compound
What is Arogyavardhini Vati?
Arogyavardhini Vati is a traditional Ayurvedic polyherbal-mineral formulation, widely revered for its broad spectrum of therapeutic actions. Its name, "Arogyavardhini," literally translates to "that which enhances health," reflecting its comprehensive benefits. This complex preparation typically combines a precise blend of purified minerals, metallic preparations (bhasmas), and potent herbal ingredients, all processed according to classical Ayurvedic texts.
Known for its balancing effect on all three doshas (Vata, Pitta, and Kapha), Arogyavardhini Vati is primarily used to support liver health, improve digestion, and detoxify the body. It is often employed in managing various chronic conditions, particularly those related to metabolic disorders and skin ailments, due to its alterative and carminative properties. The synergistic action of its diverse components contributes to its efficacy in promoting overall well-being and strengthening the body's natural defenses.
Other Names of Arogyavardhini Vati
- Arogyavardhini Gutika
- Arogyavardhini Rasa
- Sarvarogahar Vati

Benefits of Arogyavardhini Vati
Heading
<h3> Absolute Contraindications of Arogyavardhini Vati </h3> <h4> Pregnancy (If you are pregnant)</h4> <ul> <li> 🤰 <li> Recommendation: Avoid Arogyavardhini Vati during pregnancy; do not start or continue without physician review. Seek alternatives proven safe in pregnancy. <li> Reasoning: Some Ayurvedic tablets (including preparations marketed as Arogyavardhini in some cases) have been found to contain high levels of lead and mercury; prenatal exposure to these metals is linked to fetal neurodevelopmental harm, growth restriction and pregnancy complications. <li> Scientific_Study_Title: Lead poisoning in pregnant women who used Ayurvedic medications from India-New York City, 2011-2012. <li> Scientific_Study_Authors: Centers for Disease Control and Prevention (CDC). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22914225/ <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: The New York City health investigation identified six pregnant women who presented with markedly elevated blood lead levels (16-64 µg/dL) traced to oral Ayurvedic medications made in India. Analysis of the products showed lead concentrations as high as 2.4%; several products also contained mercury or arsenic. The report highlights that fetal exposure to lead can adversely affect neurodevelopment, reduce fetal growth and increase miscarriage or preterm birth risks, and recommends that providers ask pregnant patients about use of foreign or traditional remedies and consider metal exposure in prenatal screening.</p> </ul> <h4> Breastfeeding (If you are nursing / breastfeeding)</h4> <ul> <li> 🍼 <li> Recommendation: Avoid Arogyavardhini Vati while breastfeeding unless a qualified physician or toxicologist confirms the specific product is tested and safe - better to choose non-metal alternatives. <li> Reasoning: Inorganic and total mercury are known to transfer into human breast milk from maternal exposure sources; if a supplement contains mercury, the infant can be exposed via milk. <li> Scientific_Study_Title: Mercury in human colostrum and early breast milk. Its dependence on dental amalgam and other factors. <li> Scientific_Study_Authors: G. Drasch, S. Aigner, G. Roider, F. Staiger, G. Lipowsky. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/9638609/ <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: Analysis of 70 breast-milk samples showed measurable mercury in colostrum and early milk, with concentrations correlated to maternal mercury sources (e.g., dental amalgams, dietary exposures). The authors note an efficient transfer of inorganic mercury from maternal blood to milk and estimate infant exposure via milk can be a non-negligible portion of maternal burden. Although this study focused on dental and dietary sources, it establishes that maternal mercury burden translates into breast-milk exposure - a rationale for avoiding maternal ingestion of mercury-containing preparations during lactation.</p> </ul> <h4> Young children (Especially infants and toddlers)</h4> <ul> <li> 👶 <li> Recommendation: Do not give Arogyavardhini Vati to infants or young children; seek pediatric evaluation for any traditional medicine and prefer evidence-based pediatric treatments. <li> Reasoning: Case reports document severe lead and mercury poisoning in children tied to traditional/herbal remedies, including renal failure and neurodevelopmental effects; children are far more vulnerable to heavy-metal toxicity. <li> Scientific_Study_Title: Three cases of lead toxicity associated with consumption of ayurvedic medicines. <li> Scientific_Study_Authors: A. Raviraja, G. N. Vishal Babu, Anusha Sehgal, Robert B. Saper, Innocent Jayawardene, Chitra J. Amarasiriwardena, T. Venkatesh. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/21731207/ <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: The authors report three adult patients with very high blood lead levels (122.4, 115, 42.8 μg/dL) linked to Ayurvedic medicines; product testing revealed extremely high lead concentrations. After stopping the medicines and receiving chelation/nutritional support, blood lead levels and clinical status improved over months. While this report describes adults, similar case literature documents children with severe outcomes; together these findings show that metal-contaminated traditional medicines can produce clinically significant and reversible heavy-metal toxicity when exposure is identified and stopped.</p> </ul> <h4> Chronic kidney disease or significant renal impairment</h4> <ul> <li> ⚠️🩺 <li> Recommendation: Avoid Arogyavardhini Vati if you have moderate-severe chronic kidney disease unless a nephrologist approves an individually tested product; metals can concentrate in and injure kidneys. <li> Reasoning: Heavy metals (lead, mercury) are renally excreted and can worsen kidney function or accumulate in patients with reduced clearance; case reports link Ayurvedic product-related lead exposure to worsening CKD. <li> Scientific_Study_Title: Lead poisoning from an Ayurvedic herbal medicine in a patient with chronic kidney disease. <li> Scientific_Study_Authors: Suma Prakash, German T. Hernandez, Ihsan Dujaili, Vivek Bhalla. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/19384331/ <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: The report describes a 60-year-old man with diabetes and hypertension whose stage-3 chronic kidney disease was likely worsened by lead exposure from an Ayurvedic remedy. After stopping the remedy and receiving lead chelation (EDTA), the patient's whole-body lead burden and blood lead levels fell and serum creatinine returned to normal. The case underlines that lead in herbal products can exacerbate kidney disease and that cessation plus appropriate chelation can reverse the exposure effect.</p> </ul> <h4> Known recent or ongoing heavy-metal exposure / prior metal poisoning</h4> <ul> <li> 🧪 <li> Recommendation: Do not use Arogyavardhini Vati if you have known elevated body levels of lead/mercury/arsenic or are undergoing chelation therapy - discuss with a toxicologist first. <li> Reasoning: The presence of metals in some Ayurvedic preparations can add to total body burden and interfere with recovery from metal toxicity or complicate chelation management. <li> Scientific_Study_Title: Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. <li> Scientific_Study_Authors: Robert B. Saper, Russell S. Phillips, Anusha Sehgal, Nadia Khouri, Roger B. Davis, Janet Paquin, Venkatesh Thuppil, Stefanos N. Kales. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/18728265/ <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: The authors analyzed 193 Ayurvedic products and found ~20% contained detectable lead, mercury or arsenic; many exceeded safety thresholds and included both US- and Indian-manufactured items. Rasa shastra (metallurgical) products had a higher prevalence and median concentrations. The paper concludes that some marketed Ayurvedic products can be a source of clinically significant heavy-metal exposure - a reason to avoid additional metal intake in people with prior exposure.</p> </ul> <h3> Relative Contraindications of Arogyavardhini Vati </h3> <h4> Unexplained hypertension or catecholamine-like syndromes</h4> <ul> <li> ⚠️ <li> Recommendation: Use with caution and only under medical supervision if you have hard-to-control hypertension; stop the product and evaluate heavy-metal exposure if new hypertension appears. <li> Reasoning: Mercury exposure from some traditional medicines has been reported to cause severe hypertension and pheochromocytoma-like syndromes that are difficult to control until exposure stops. <li> Scientific_Study_Title: Mercury intoxication and arterial hypertension: report of two patients and review of the literature. <li> Scientific_Study_Authors: A. D. Torres, A. N. Rai, M. L. Hardiek. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/10699136/ <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: The paper describes two patients whose mercury intoxication produced marked arterial hypertension and reviews literature linking mercury exposure to hypertension and autonomic disturbances. The authors emphasize that hypertension due to mercury may be resistant to conventional therapy until the source is removed and chelation considered, supporting caution when metal-containing traditional medicines are used by hypertensive patients.</p> </ul> <h4> Concurrent use of multiple metal-containing traditional remedies (additive metal exposure)</h4> <ul> <li> ➕ <li> Recommendation: Avoid combining multiple untested Ayurvedic/herbomineral products; if you take any, have them tested or consult a qualified clinician. <li> Reasoning: Independent analyses show many products contain metals; taking several such products increases total daily metal intake and raises toxicity risk. <li> Scientific_Study_Title: Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. <li> Scientific_Study_Authors: Robert B. Saper et al. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/18728265/ <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: The comparative analysis of internet-sold Ayurvedic medicines found one-fifth contained toxic metals and that products labeled as rasa shastra were more likely to carry high metal loads; multiple product use would therefore increase cumulative exposure, which can exceed regulatory intake standards and raise health risk.</p> </ul> <h4> Use with nephrotoxic medications (e.g., certain antibiotics, NSAIDs) - caution</h4> <ul> <li> ⚠️ <li> Recommendation: If you take known nephrotoxic drugs, consult a physician before starting Arogyavardhini Vati; monitor kidney function closely. <li> Reasoning: Heavy metals concentrate in kidneys and can cause or worsen renal injury; combining any metal-containing product with nephrotoxic drugs may increase AKI risk. <li> Scientific_Study_Title: Interstitial nephritis presenting as acute kidney injury following ingestion of alternative medicine containing lead: a case report. <li> Scientific_Study_Authors: (Case report authors as listed on PubMed). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/31172119/ <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: The case report describes a patient who developed acute kidney injury and interstitial nephritis after ingesting a non-specified alternative medicine containing lead. The authors highlight that herbal remedies can be an underrecognized cause of AKI and recommend clinicians ask about alternative medicine use when patients present with unexplained renal dysfunction.</p> </ul>
Heading
<h4> Heavy-metal accumulation / metal-toxicity signs (lead, mercury, arsenic) </h4> <ul> <li> 🧬 <li> Side effect summary: Some batches of Arogyavardhini (and many rasa-shastra or untested Ayurvedic products) can contain heavy metals; chronic use may lead to accumulation causing abdominal pain, anemia, neurologic symptoms, hypertension or kidney injury. <li> Recommendation: Stop product if you develop unexplained gastrointestinal, neurological, hematologic, renal or hypertensive symptoms; get blood/urine metal testing and consult a physician or poison control center for management. <li> Reasoning: Analytical and clinical reports link Ayurvedic product use to raised blood/urine lead and mercury and to clinical heavy-metal poisoning syndromes; chelation and stopping the product are key interventions. <li> Severity Level: Severe <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. <li> Scientific_Study_Authors: Robert B. Saper, Russell S. Phillips, Anusha Sehgal, Nadia Khouri, Roger B. Davis, Janet Paquin, Venkatesh Thuppil, Stefanos N. Kales. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/18728265/ <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: Among 193 analyzed Ayurvedic products purchased over the internet, ~21% contained detectable lead, mercury or arsenic; many exceeded acceptable daily intake standards. Rasa shastra (metal-incorporating) medicines showed higher prevalence and median metal concentrations. The authors conclude that users of Ayurvedic medicines may be at risk for heavy-metal toxicity and recommend testing and tighter regulation.</p> </ul> <h4> Kidney injury / acute interstitial nephritis </h4> <ul> <li> 🧾 <li> Side effect summary: Heavy-metal-contaminated traditional medicines have been reported to cause acute kidney injury (AKI), tubulointerstitial nephritis and worsening of chronic kidney disease. <li> Recommendation: If you experience reduced urine output, swelling, severe fatigue, or bloodwork abnormality after taking such medicines, stop and seek urgent medical care; CKD patients should avoid these products unless cleared by a nephrologist. <li> Reasoning: Cases document AKI and biopsy-proven interstitial nephritis after ingestion of mercury- or lead-containing products; kidneys are a primary excretory route for many metals. <li> Severity Level: Severe <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Acute renal failure secondary to ingestion of ayurvedic medicine containing mercury. <li> Scientific_Study_Authors: K. Sathe, U. Ali, A. Ohri (and case report team as published). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/ (case available via Indian J Nephrol full text; see https://indianjnephrol.org/acute-renal-failure-secondary-to-ingestion-of-ayurvedic-medicine-containing-mercury/ ) <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: A reported case of a 2-year-old who developed anuric renal failure following months of ingestion of an Ayurvedic preparation found to contain very high mercury levels (≈2066 ppm). Renal biopsy showed tubulointerstitial nephritis; treatment (dialysis, steroids, chelation) led to recovery. The report underscores pediatric vulnerability and the potential for severe renal injury from contaminated traditional medicines.</p> </ul> <h4> Neurologic symptoms (paresthesia, tremor, cognitive changes) </h4> <ul> <li> 🧠 <li> Side effect summary: Chronic mercury or lead exposure from contaminated products can lead to tremor, memory/attention problems, mood changes, neuropathy or developmental delay in children. <li> Recommendation: Discontinue suspect product, arrange neuro and toxicology assessment, and consider metal testing; for severe neurologic signs, seek urgent care. <li> Reasoning: Clinical series and case reports link Ayurvedic product-related exposures to neurologic manifestations that improve when exposure stops and appropriate therapy is given. <li> Severity Level: Moderate to Severe <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Elemental mercury intoxication in 7 patients admitted to a pediatric rheumatology clinic. <li> Scientific_Study_Authors: Paç Kısaarslan A, Sözeri B, Baştuğ F, Gündüz Z, Yel S, Nalçacıoğlu H, Şahin N, Özdemir Çiçek S, Poyrazoğlu H, Düşünsel R. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32105014/ <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: This pediatric case series describes patients with elemental mercury intoxication presenting with extremity pain, neuropathy, tubulopathy and hypertension; several had neurologic symptoms and peripheral neuropathy. The authors emphasize multisystem involvement of mercury intoxication and the need for timely recognition and management to avoid long-term sequelae.</p> </ul> <h4> Gastrointestinal upset (nausea, abdominal pain) </h4> <ul> <li> 🤢 <li> Side effect summary: Some users report nausea, abdominal pain or GI upset after taking contaminated or concentrated herbal/mineral preparations. <li> Recommendation: If GI symptoms are persistent or severe, stop the product and consult a clinician; investigate for metal exposure if symptoms are unexplained. <li> Reasoning: GI symptoms are common early manifestations of heavy-metal ingestion and are reported in case series of Ayurvedic product-linked toxicity. <li> Severity Level: Mild to Moderate <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Lead intoxication due to ayurvedic medications as a cause of abdominal pain in adults. <li> Scientific_Study_Authors: (See case series authors on PubMed; example observational study references available). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/27957879/ <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: In an observational series of patients with unexplained recurrent abdominal pain, many had elevated blood lead levels and a history of Ayurvedic medicine intake; common presenting features included abdominal pain, constipation, anemia and abnormal liver tests. Cessation of the medicines and chelation led to clinical and lab improvement.</p> </ul>
Heading
<h4> Antihypertensive medications (clinical management interaction)</h4> <ul> <li> Interaction_Details: Mercury exposure from contaminated herbal products can produce marked, treatment-resistant hypertension or pheochromocytoma-like syndromes that complicate control with usual antihypertensives until the source is removed and appropriate toxicology treatment begun. <li> Severity: Severe <li> Recommendation: If uncontrolled hypertension appears or worsens after starting Arogyavardhini Vati, stop the product and evaluate for metal exposure; consult a toxicologist and manage BP aggressively while investigating exposure. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/10699136/ <li> Scientific_Study_Title: Mercury intoxication and arterial hypertension: report of two patients and review of the literature. <li> Scientfic_Study_Authors: A. D. Torres, A. N. Rai, M. L. Hardiek. <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: This report details two patients whose mercury intoxication produced severe hypertension and reviews literature linking mercury exposure to autonomic and catecholamine-like disturbances; the authors note that blood pressure may not normalize until exposure ceases and chelation is considered, indicating a clinically important interaction with antihypertensive management in affected patients.</p> </ul> <h4> Concomitant use of other metal-containing Ayurvedic/herbal products (additive exposure)</h4> <ul> <li> Interaction_Details: Taking multiple metal-containing formulations together increases cumulative heavy-metal intake and the risk of toxicity; this is a cumulative exposure interaction rather than a classic pharmacologic drug-drug interaction. <li> Severity: Moderate <li> Recommendation: Avoid combining multiple untested mineral/herbomineral products; have product analysis or discuss with a clinician to confirm safety. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/18728265/ <li> Scientific_Study_Title: Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. <li> Scientfic_Study_Authors: Robert B. Saper et al. <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: The investigators found that roughly 20% of tested Ayurvedic products sold online contained detectable toxic metals and that rasa shastra products (those intentionally including metals) were more likely to have high concentrations; therefore combining multiple such products raises cumulative metal exposure beyond safe thresholds.</p> </ul> <h4> Nephrotoxic medications (e.g., aminoglycosides, high-dose NSAIDs, certain chemotherapies) - potential additive renal risk</h4> <ul> <li> Interaction_Details: Because some metal species preferentially accumulate in the kidney and can cause tubular/interstitial injury, concurrent use with nephrotoxic drugs could increase risk of acute kidney injury. <li> Severity: Moderate <li> Recommendation: If you require nephrotoxic drugs, avoid Arogyavardhini Vati unless product quality is confirmed and kidney function is monitored closely; consult a nephrologist. <li> Scientific_Study_Available: Yes (case reports) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/31172119/ <li> Scientific_Study_Title: Interstitial nephritis presenting as acute kidney injury following ingestion of alternative medicine containing lead: a case report. <li> Scientfic_Study_Authors: (Authors as listed on PubMed entry) <li> Scientific_Study_Excerpt: <p>Paraphrase of study findings: The case report describes AKI and interstitial nephritis following use of an alternative medicine containing lead, emphasizing that herbal remedies can be hidden causes of renal injury and that co-exposure with nephrotoxic agents may raise the risk of clinical renal dysfunction.</p> </ul> <h4> Chelation therapy (therapeutic interaction / management implication)</h4> <ul> <li> Interaction_Details: If a patient is undergoing chelation for prior metal poisoning, initiating a metal-containing product will counteract chelation efforts and increase total body burden. <li> Severity: Severe <li> Recommendation: Never start Arogyavardhini Vati when actively receiving chelation; only resume (if ever) after expert toxicology clearance and product verification. <li> Scientific_Study_Available: NA (no direct pharmacologic interaction trials found specific to Arogyavardhini and chelators, but clinical management guidance is standard in toxicology literature) <li> Scientific_Study_Link: NA <li> Scientific_Study_Title: NA <li> Scientfic_Study_Authors: NA <li> Scientific_Study_Excerpt: <p>NA</p> </ul>